There will be an article by article review of the initiative to reform the Law on Subcontracting or outsourcing , as agreed by the private sector with President Andrés Manuel López Obrador ; and after a week, they will return to the National Palace to present what was agreed with their cabinet, informed Carlos Salazar Lomelín, president of the Business Coordinating Council (CCE).

Without anticipating modifications to the bill sent by the Executive to the Chamber of Deputies, he pointed out that there is dialogue and they will be in “permanent session” with the officials in charge of the initiative.

“I cannot assure it (a modification) until we sit down with the cabinet and see article by article what is being proposed as we suggest,” he said at the end of the meeting, which lasted a little more than an hour. and a half and to which the presidents of the Confederation of Industrial Chambers of Mexico (Concamin) and the Confederation of National Chambers of Commerce, Services and Tourism (Concanaco Servytur), both legitimate representatives of the national secondary and tertiary sectors, also attended.

“We made a commitment, here next week, and we will already reach the agreement that we will have seen with the cabinet,” said the leader of the highest business leadership.

This Monday, in his morning conference, President Andrés Manuel López Obrador left the door open for a possible modification to the proposal to extinguish the labor subcontracting mechanism known as outsourcing, and summoned representatives of the private sector “to explain” the initiative sent to the Chamber of Deputies.

He explained that as part of the violations of the rights of subcontracted workers, every year there is a cyclical fall in employment in December.

He pointed out that “due to the maneuver” made by the entrepreneurs in December 2019, 382,210 jobs and 378,560 jobs were lost in the same month of 2018.

Flexibility to changes
The president accepted that a way could be found to allow this outsourcing practice under certain conditions.

“They have to prove that it is not this, because we would not allow… we would look for a way, even also a call to employers, because as in everything there are employers who treat their workers well, who guarantee their benefits and others who act improperly ”Said the chief executive.

By instructions of the president, his cabinet is in “permanent session” together with representatives of the private sector to exchange opinions and concerns, said Luisa María Alcalde, Secretary of Labor.

“We are in ‘permanent session’ to be able to listen to each other, to be able to give our reasons, to see what the effects have been on the workers, the public finances, the social security institutions, and we will also listen to the employers. What is going to take place is dialogue, “he said at the end of the meeting at the National Palace.

Among business leaders there was optimism as they left the meeting at least for the opportunity to be heard in their concerns.

“We believe that the meeting went very well. He asked us to stay in ‘permanent session’. They are going to listen to all our concerns, ”said Salazar Lomelín.

“We spoke with the president and the cabinet that has to do with work and it was declared in ‘permanent session’ to reach an agreement in order to have confidence,” said Francisco Cervantes, president of Concamin, who confirmed that the next meeting It is for Monday, November 30.

Infrastructure Plan Advances
The meeting between the private initiative and the Executive with his cabinet focused on the issue of the outsourcing reform initiative. The subject of the second package of infrastructure projects in which private investment can participate was not touched; However, Salazar Lomelín announced that progress is being made in its formation.

“Progress continues in the infrastructure plan and it is most likely that very soon we will be announcing the second stage,” he said.

For the financial industry, the dream of making money out of just a two hours of work every single week is completely unrealistic. A lot of people might assume and start out thinking like this, thinking that they can get rich quick because they know the industry that they are in already. The truth is there are a lot more ideas and plans out there to make a fortune in any industry than you think. If you’ve never heard of any of them, then make sure that you become informed and careful. As I, Alexey Khobot, tell my clients, all it takes is a little education, a plan of action and some focused action on the tasks that you need to do to achieve big results. For those who actually know something that they think could be a future six-figure income earner, the key is to break the cycle by having a mindset of a true entrepreneur.

I’m going to therefore try to develop some of the good ideas you will need to get you if you are really serious about starting your own business.

Educate you on the area you want to work in. If you choose to sell online, you have to understand the ins and outs of the business. Will you be targeting people in the US or international and what does that mean. Also, understanding the competition you are going up against is also vital information. You need to know if you are going to be able to survive the competition or not. A major piece of the puzzle is educating yourself about the industry in which you want to work in. Know the difference and how it can affect the way that you operate and market. Understand that the amount of money you make is directly related to the quality of work you put in.

One of the first tasks that you will need to be able to do is the basics explains Alexey Khobot: The basics are the very easy things to do in which you must do. You want to educate yourself about the 6Ps in which you want to be educating yourself in. These are to be interesting, the product is far more important than the way you go about explaining it. You need to know how to entice your audience as well as attract the ones that want to buy what you are offering. The rest of the program will come along after you’ve spent some time inundating yourself with the basics. So start out with the basics and then when you want to spend money or learn more advanced pieces of the puzzle.

Anyway, the basics are so feel free to do as you please. You are just concentrating on the part where you want to go out and write it down in a notebook. You will find that this becomes a fundamental process. After you have written down your general picture of your business, you now start to become more familiar with what you will ultimately be doing.

Now is the time to participate in your new business enthuses Alexey Khobot. Even if it seems that there is no plan or document, it is important to develop a vision for your future. How it’s going to look, how much it’s going to cost you and how you’re going to go about achieving that goal. Some people do all of this a natural way while others take it to another level and map out exactly how they’re going to achieve each goal. Regardless, it is important to have some kind of plan or document in place.

So you see, it really does started out with educating yourself and as you go along, you will learn a lot whether it’s simply going down the simple route of educating yourself on what is available. Right now we have outlined some of the important parts that you need to be able to convey to people who are interested in what you have to say. You won’t know what to tell the people that will be answering your questions. It might be okay if you get an email or two from them but eventually they will start to throw you the information that you need. Today it’s the “yes tomorrow” scenario. You won’t work out what you will say in future. Now, it’s up to you because we’ve still got the education that you need. Remember though that if you want to succeed and be a small business person, you will have to work plan a business and not a way of life. You have to spend with discipline, take risks and captivate the customers to achieve the type of lifestyle that you desire.

The news reached Sarah Gilbert on Saturday night that the COVID-19 vaccine she developed with AstraZeneca seemed to work, but the Oxford University professor hoped for a key number: Was it more than 90 percent effective, as have been others, or less?

Instead, when his colleague Andrew Pollard called with the results, he wanted to show him slides instead of simple figures . “I really didn’t understand why we had to go through slides,” he recalled. “But then it became clear: because it is much more complicated in our test.”

That complexity has led to uncertainty surrounding one of the pioneers along with Pfizer, BioNTech and Moderna in the ‘race’ for a dose to end the pandemic. Questions about the most effective dose of the vaccine, its safety record, and partners’ approach to testing it have cast doubt on whether the US Food and Drug Administration (FDA) will endorse it.

AstraZeneca and Oxford reported the results early Monday after 131 trial participants in the UK and Brazil contracted COVID-19. The average prevention efficacy of 70 percent sounded good , within analyst expectations, and above the 50 percent standard the FDA had set for COVID vaccines.

The study also found 16 serious cases, all among people who received vaccine from AstraZeneca , according to Moncef Slaoui, the exinvestigador of GlaxoSmithKline who runs the program Operation Warp Speed US. It was good news for Astra’s vaccine program that had been on hold for six weeks in that country while regulators reviewed a serious adverse event that the company never gave details about. Oxford will report the details of these adverse events in its efficacy study which it will present for review in the coming weeks.

Shares of AstraZeneca rose as much as 2.4 percent early Tuesday morning in London after falling 3.8 percent on Monday.

The puzzling part of Astra’s results was that the larger doses were less effective. The vaccine was only 62 percent effective in a group that received two full doses about a month apart, but among about 2,700 people who received a half dose followed by a full one , the effectiveness rose to 90 percent.

Positive data from another vaccine of substantial efficacy with potential advantages in storage, transportation and affordability will be welcome , said Jesse Goodman, a former chief of the FDA’s office of vaccines who later became the agency’s chief scientist.

“What is not yet clear is whether this effect is a chance observation or reflects that the higher dose can negatively affect the immune response ,” he said in an interview. “We need more details to begin to understand it.”

Geoffrey Porges, an analyst at SVB Leerink, was among the most critical voices, calling the data “premature and insufficient” in a note to clients and predicting that the vaccine would “never be licensed in the US.”

Arm yourself with patience
AstraZeneca and Oxford are conducting trials of the vaccine in different parts of the world , and are currently only studying two full doses of the dose in their US study, which is expected to include 30,000 volunteers. But the company is still recruiting participants and could add another analysis for further studies of the half-dose regimen, explained Ruud Dobber, executive vice president and president of biopharmaceuticals at AstraZeneca.

“Let’s be a little more patient and see how the FDA reacts before making such harsh statements,” he said in an interview with Bloomberg TV .

The UK Medicines and Healthcare Products Regulatory Agency has already started its analysis based on the data it has received in ongoing review, Chief Executive June Raine said in a statement.

It may interest you: Why the AstraZeneca vaccine, which will be packaged in Mexico, may be the best option?

Low- and middle-income nations are looking to the injection, priced much lower than Pfizer and Moderna, as a way out of the pandemic. The lower efficacy number of the two full-dose regimens reached the World Health Organization benchmark, according to chief scientist Soumya Swaminathan.

Still, Swaminathan warned in an interview Tuesday with Bloomberg Television that more comprehensive data is needed to understand possible discrepancies between doses.

“We really need to wait for bigger numbers, longer follow-up, to see if these differences really continue into the future,” he said.

That a lower dose produced a better result left even Gilbert scratching his head . The researchers tested a starting half-dose regimen to find the smallest amount that could still elicit a strong immune response , Gilbert said, not to increase effectiveness.

“I was surprised,” he said in an interview. “I really didn’t expect that.”

Its superiority over two full doses could be good news, as it would allow the company to perform more inoculations with the same total volume of vaccine . That could be important with the need to vaccinate billions of people around the world.

The vaccine uses a harmless chimpanzee adenovirus , the cause of some common colds, as a vector that is then inserted with the coronavirus spike protein to elicit an immune response.

What could have caused these results?
In theory, it is possible that a full initial dose raised antibodies against the adenovirus vector itself, which could have limited the immune response to the peak protein of the SARS-CoV-2 virus, Gilbert said, but his team measured antibodies against it. adenovirus in previous studies and found only a small effect.

“I’m not really sure if that’s the complete answer. We’ll look into it a bit more, but it may be a bit more subtle in terms of inducing a high-quality immune response by giving just the right amount of vaccine antigen in the first dose and then expanding it with the second dose, “he added.

One possible explanation for the variable results is that the lower starting dose does a better job of breaking through the body’s defenses , allowing the vaccine to infect cells and create the immune response, said Michael Kinch, an expert in drug development and Associate Vice Chancellor at Washington University in St. Louis.

Another theoretical reason is more complex: the immune system can become immune to the initial high dose of vaccine and then ignore the subsequent dose, a phenomenon known as immune tolerance or desensitization. Either one would have the potential to mitigate the effects of the vaccine.

“The 90 percent number may ultimately prove correct,” Kinch said, “but the dose-response reversal could be a sign of concern.”

The Oxford team is still analyzing their data to better understand how the vaccine works. Gilbert noted that he is confident that the higher efficiency number will stick around as more data arrives.

“It could go up or down a bit,” he said. “I don’t think it’s going to change massively, but it may differ from that initial 90 percent in either direction when we get to a little bigger analysis.”